What is the current state of research on long-term therapy using PARP inhibitors in patients with BRCA mutations?

Hassan GHAZAL
oncologist, Dubai
CONTINUE READING

What are the key findins of the PATINA trial for patients with hormone receptor-positive, HER2-positive metastatic breast cancer ?

Hassan GHAZAL
oncologist, Dubai
CONTINUE READING

What are the update of DESTINY BREAST 12 in HER2 positive disease with brain metastatis ?

Hassan GHAZAL
oncologist, Dubai
CONTINUE READING

Shared Decision-Making in Breast Cancer Treatment.

Hassan GHAZAL
CONTINUE READING

Medical Oncology: Targeted Therapies.

Hassan GHAZAL
CONTINUE READING

What are the options in HER2 postive breast cancer treatments are we moving to t-DXd in first line?

Hassan GHAZAL
oncologist, Dubai
CONTINUE READING

How important are side effects, especially pulmonary toxicity, and how do you manage them?

Hassan GHAZAL
oncologist, Dubai
CONTINUE READING

Where does immunotherapy take place in breast cancer, is there a potential in HER2 positive patients?

Hassan GHAZAL
oncologist, Dubai
CONTINUE READING

Copyright © 2025 - BCU